APA

National Cancer Institute (U.S.), . (1975). Serum levels of N2,N2 dimethylguanosine and pseudouridine as determined by radioimmunoassay for patents [sic] with malignancy. [Washington, D.C: .

Chicago

National Cancer Institute (U.S.), . 1975. Serum levels of N2,N2 dimethylguanosine and pseudouridine as determined by radioimmunoassay for patents [sic] with malignancy. [Washington, D.C: .

Harvard

National Cancer Institute (U.S.), . (1975). Serum levels of N2,N2 dimethylguanosine and pseudouridine as determined by radioimmunoassay for patents [sic] with malignancy. [Washington, D.C: .

MLA

National Cancer Institute (U.S.), . Serum levels of N2,N2 dimethylguanosine and pseudouridine as determined by radioimmunoassay for patents [sic] with malignancy. [Washington, D.C: . 1975.